Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease

BACKGROUND: Proton pump inhibitors (PPIs) are frequently prescribed to patients with coronary heart disease (CHD) under antiplatelet therapy to prevent gastrointestinal (GI) bleeding. However, its clinical impact is still under debate, especially in Asian population. This study was undertaken to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wanbing, Shu, Xiaorong, Zhu, Enyi, Deng, Bingqing, Lin, Yongqing, Wu, Xiaoying, Zhou, Zenan, Wang, Jingfeng, Nie, Ruqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863361/
https://www.ncbi.nlm.nih.gov/pubmed/33546595
http://dx.doi.org/10.1186/s12872-021-01884-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863361/
https://www.ncbi.nlm.nih.gov/pubmed/33546595
http://dx.doi.org/10.1186/s12872-021-01884-z

Ejemplares similares